Illumina faces record fine over purchase of Grail without EU approval
ILMN prezzo e grafico azione — NASDAQ:ILMN — TradingView
Illumina, Inc.
Illumina, Inc. - Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
Illumina vince l'appello accelerato dell'ordine della FTC di cedere Grail -19 aprile 2023 alle 19:14 | MarketScreener
Illumina, Inc. | San Diego CA
Illumina Hit With €432 Million EU Fine for Hasty Grail Deal - Bloomberg
Sequenziatore di nuova generazione per DNA - iSeq 100 - Illumina, Inc. - per RNA / da laboratorio / tramite semiconduttori
ILMN Intrinsic Valuation and Fundamental Analysis - Illumina Inc - Alpha Spread
Sequenziatore di nuova generazione per DNA - MiSeq - Illumina, Inc. - da laboratorio
Illumina | Sequencing and array-based solutions for genetic research
Careers | Biotech and genomics job opportunities
ILMN Stock Analysis: Illumina Inc. to Give Breakdown Soon?
Illumina | Sequencing and array-based solutions for genetic research
Signal: Illumina to divest Grail, ending years-long legal battle - Medical Device Network
Illumina Wins Case Against FTC on Grail Acquisition - WSJ
In questa foto è illustrato il logo di Illumina, Inc. Visualizzato su uno smartphone Foto stock - Alamy
Illumina, Inc. - Illumina, Inc. added a new photo.
Illumina, Inc. - Illumina celebrates 25 years of innovation
illumina, Inc. | AsymmetricA
Illumina cuts annual profit forecast as biotech funding woes linger | Reuters
About Us | A global leader in genomics
Signal: Illumina leads $15m investment in Broken String Biosciences - Pharmaceutical Technology
Sequenziatore di nuova generazione per DNA - NextSeq 550 - Illumina, Inc. - per RNA / da laboratorio
Illumina acquires Enancio's compression software
